University of South Florida
OrganisationROR
People
Associate professor19 Sept 2026reporter.nih.gov
Associate professor4 Sept 2026reporter.nih.gov
Graduate research assistant17 Aug 2026reporter.nih.gov
Professor, endowed chair, director17 Jul 2026reporter.nih.gov
Assistant professor9 Jun 2026reporter.nih.gov
Professor3 Jun 2026reporter.nih.gov
12 May 2026reporter.nih.gov
Professor12 May 2026reporter.nih.gov
Professor12 May 2026reporter.nih.gov
Associate professor24 Apr 2026reporter.nih.gov
Professor9 Apr 2026reporter.nih.gov
2 Apr 2026reporter.nih.gov
Assistant professor23 Mar 2026reporter.nih.gov
Research associate professor23 Mar 2026reporter.nih.gov
Associate professor10 Mar 2026reporter.nih.gov
Trials
Early phase 1Terminated202211 people14 Jul 2022clinicaltrials.gov
CollaboratorPhase 2Completed202286 people26 Oct 2021clinicaltrials.gov
Phase 4Status unknown2020183 people4 Aug 2020clinicaltrials.gov
CollaboratorPhase 2Completed201514 people5 Nov 2015clinicaltrials.gov
Phase 3Completed201591 people5 Nov 2014clinicaltrials.gov
Phase 4Completed201074 people29 Apr 2010clinicaltrials.gov
Phase 2Completed200920 people9 Oct 2009clinicaltrials.gov
Phase 2/3Terminated200928 people8 Dec 2008clinicaltrials.gov
Phase 2Terminated200517 people26 Sept 2008clinicaltrials.gov
Phase 4Withdrawn20070 people2 Jan 2008clinicaltrials.gov
Phase 2Terminated20077 people1 Feb 2007clinicaltrials.gov
Grants and prizes
R03Cancer screening validation study design using optimal two-phase sampling schemesR03CA317744US$150k2026–202819 Sept 2026reporter.nih.gov
R21The impact of oligodendrocyte APP expression in Alzheimer's disease mouse modelsR21AG101027US$412.5k2026–20284 Sept 2026reporter.nih.gov
National Institute on Deafness and Other Communication Disorders
F32Parallel training in human and animal studies to evaluate the effects of age-related changes to extended high frequency sensitivity and cognition on higher-order auditory processingF32DC023413US$83.9k2025–202817 Aug 2026reporter.nih.gov
R015-HT 2C Receptor and Alzheimer's DiseaseR01AG080392US$578.6k2023–202817 Jul 2026reporter.nih.gov
R01Elucidating the mechanism of erythropoietin (EPO) in mitigating Dry-AMD pathophysiologyR01EY033415US$412.9k2022–20279 Jun 2026reporter.nih.gov
R01Transcriptome-wide mapping of brain m6A methylome in Alzheimer’s diseaseR01AG095602US$786.7k2025–20303 Jun 2026reporter.nih.gov
R01Molecular Targets Modulating Neuro COVID Sequelae Linked to TauopathyR01AG086245US$750k2024–202912 May 2026reporter.nih.gov
R33Protease Resistant Growth Factor Nanoparticles for Chronic Wound HealingR33AG077426US$353.4k2023–202824 Apr 2026reporter.nih.gov
R01Brain and blood N-glycome profiling in Alzheimer's diseaseR01AG085469US$739.7k2024–202921 Apr 2026reporter.nih.gov
R01Mechanisms of Trabecular Meshwork Regeneration by Stem CellsR01EY025643US$455.8k2015–20279 Apr 2026reporter.nih.gov
R015-HT 2C Receptor and Alzheimer's DiseaseR01AG080392US$547.2k2023–20288 Apr 2026reporter.nih.gov
National Heart, Lung, and Blood Institute
R01PSAT1 modified mRNA induces cardiac repair post-ischemic heart injuryR01HL169872US$375k2025–20292 Apr 2026reporter.nih.gov
National Institute of Neurological Disorders and Stroke
R01The role of SARS-CoV-2-induced senescence in the development of Alzheimer's DiseaseR01NS138600US$369.8k2025–203023 Mar 2026reporter.nih.gov
National Institute on Deafness and Other Communication Disorders
R01Functional spatial segregation in auditory scene analysisR01DC020514US$483.4k2023–202823 Mar 2026reporter.nih.gov
R01Cognitive training to reduce incidence of cognitive impairment in older adultsR01AG070349US$2.9m2021–202710 Mar 2026reporter.nih.gov
R01Cognitive training to reduce incidence of cognitive impairment in older adultsR01AG070349US$10.3m2021–202726 Feb 2026reporter.nih.gov